Cited by 404Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia ResearchPlatelet Disorders and Treatments

Myeloproliferative Neoplasms

Spivak, Jerry L.·2017·New England Journal of Medicine

Abstract

The myeloproliferative disorders, comprising polycythemia vera, essential thrombocytosis, and myelofibrosis, are clonal hematopoietic cancers that have an indolent course. The clinical manifestations of these entities overlap, as do their genetic drivers.

Integrity signals

Registry

Crossref · 10.1056/nejmra1406186

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These cytokines display overlapping features, such as inducing cell cycle entry of HSCs and their differentiation, frequently toward the granulo-monocytic lineage.

    “These cytokines display overlapping features, such as inducing cell cycle entry of HSCs and their differentiation, frequently toward the granulo-monocytic lineage 1,4-6,12-15 .”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Spivak, J. L.
Affiliations
Johns Hopkins University (US)
Corresponding author
Spivak, Jerry L.
Venue
New England Journal of Medicine
Published
2017-06
Volume
376
Issue
22
Pages
2168-2181
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4249369999
Cited by
404
References
2
Citations by year
2026: 31 · 2025: 35 · 2024: 37 · 2023: 46 · 2022: 50 · 2021: 70 · 2020: 56 · 2019: 40 · 2018: 27 · 2017: 12
FWCI
5.16
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Keywords
myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, myelofibrosis, indolent disease, driver genes, clinical features
MeSH terms
Age Factors, Antineoplastic Agents, Female, Hematopoietic Stem Cells, Humans, Male, Mutation, Myeloproliferative Disorders, Phenotype, Polycythemia Vera, Sex Factors, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Gene Expression, Bone Marrow Transplantation, Primary Myelofibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review